Moderna testing potential monkeypox vaccines
May 24, 2022, 8:47 AM EDT
(Reuters) – Moderna Inc (MRNA.O) is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.
Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration
The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads. read more
Moderna did not immediately respond to a request for more details on the monkeypox vaccines.
The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S (BAVA.CO), for use in monkeypox cases. read more
Our Standards: The Thomson Reuters Trust Principles.
Reuters source:
